Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. United States Anesthesia Drugs Market


6. Share Analysis – United States Anesthesia Drugs Market

6.1 Anesthesia Drugs
6.2 General Inhalation Anesthesia Drugs Market
6.3 General Intravenous Anesthesia Drugs
6.4 Local Anesthesia Drugs


7. Types – United States Anesthesia Drugs Market

7.1 General Inhalation Anesthesia Drugs Market
7.2 General Intravenous Anesthesia Drugs Market
7.3 Local Anesthesia Drugs Market


8. General Inhalation Anesthesia Drugs Market

8.1 Sevoflurane
8.2 Desflurane
8.3 Isoflurane
8.4 Others


9. General Intravenous Anesthesia Drugs Market

9.1 Propofol
9.2 Etomidate
9.3 Ketamine
9.4 Barbiturates


10. Local Anesthesia Drugs Market

10.1 Bupivacaine
10.2 Ropivacaine
10.3 Lidocaine
10.4 Chloroprocaine
10.5 Prilocaine
10.6 Benzocaine
10.7 Other local anesthetics


11. Merger & Acquisition (M&A) – United States Anesthesia


12. Reimbursement Policy – United States Anesthesia Drugs Market

12.1 Private Health Insurance Providers

12.1.1 Aetna International
12.1.2 Coventry Health Care
12.1.3 Anthem Blue Cross and Blue Shield
12.1.4 Blue Cross and Blue Shield of Texas
12.1.5 United Healthcare

12.2 Public Health Insurance Providers

12.2.1 Medicare
12.2.2 MDWise


13. Porter’s Five Forces – United States Anesthesia Drugs Market

13.1 Bargaining Power of Buyers
13.2 Bargaining Power of Suppliers
13.3 Degree of Rivalry
13.4 Threat of New Entrants
13.5 Threat of Substitutes


14. SWOT Analysis – United States Anesthesia Drugs Market

14.1 Strength
14.2 Weakness
14.3 Opportunity
14.4 Threat


15. Key Players Analysis

15.1 Baxter International Inc.

15.1.1 Overview
15.1.2 Recent Development
15.1.3 Revenue

15.2 Abbvie

15.2.1 Overview
15.2.2 Recent Development
15.2.3 Revenue

15.3 Medtronic Plc

15.3.1 Overview
15.3.2 Recent Development
15.3.3 Revenue

15.4 Draegerwerk AG

15.4.1 Overview
15.4.2 Recent Development
15.4.3 Revenue

15.5 Koninklijke Philips NV

15.5.1 Overview
15.5.2 Recent Development
15.5.3 Revenue

15.6 Abbott Laboratories

15.6.1 Overview
15.6.2 Recent Development
15.6.3 Revenue



List of Figures

Figure-01: United States – Anesthesia Drugs Market (Billion US$), 2018 – 2023
Figure-02: United States – Forecast for Anesthesia Drugs Market (Billion US$), 2024 – 2030
Figure-03: Type – General Inhalation Anesthesia Drugs Market Market (Million US$), 2018 – 2023
Figure-04: Type – Forecast for General Inhalation Anesthesia Drugs Market Market (Million US$), 2024 – 2030
Figure-05: Type – General Intravenous Anesthesia Drugs Market Market (Million US$), 2018 – 2023
Figure-06: Type – Forecast for General Intravenous Anesthesia Drugs Market Market (Million US$), 2024 – 2030
Figure-07: Type – Local Anesthesia Drugs Market Market (Million US$), 2018 – 2023
Figure-08: Type – Forecast for Local Anesthesia Drugs Market Market (Million US$), 2024 – 2030
Figure-09: General Inhalation Anesthesia – Sevoflurane Market (Million US$), 2018 – 2023
Figure-10: General Inhalation Anesthesia – Forecast for Sevoflurane Market (Million US$), 2024 – 2030
Figure-11: General Inhalation Anesthesia – Desflurane Market (Million US$), 2018 – 2023
Figure-12: General Inhalation Anesthesia – Forecast for Desflurane Market (Million US$), 2024 – 2030
Figure-13: General Inhalation Anesthesia – Isoflurane Market (Million US$), 2018 – 2023
Figure-14: General Inhalation Anesthesia – Forecast for Isoflurane Market (Million US$), 2024 – 2030
Figure-15: General Inhalation Anesthesia – Others Market (Million US$), 2018 – 2023
Figure-16: General Inhalation Anesthesia – Forecast for Others Market (Million US$), 2024 – 2030
Figure-17: General Intravenous Anesthesia – Propofol Market (Million US$), 2018 – 2023
Figure-18: General Intravenous Anesthesia – Forecast for Propofol Market (Million US$), 2024 – 2030
Figure-19: General Intravenous Anesthesia – Etomidate Market (Million US$), 2018 – 2023
Figure-20: General Intravenous Anesthesia – Forecast for Etomidate Market (Million US$), 2024 – 2030
Figure-21: General Intravenous Anesthesia – Ketamine Market (Million US$), 2018 – 2023
Figure-22: General Intravenous Anesthesia – Forecast for Ketamine Market (Million US$), 2024 – 2030
Figure-23: General Intravenous Anesthesia – Barbiturates Market (Million US$), 2018 – 2023
Figure-24: General Intravenous Anesthesia – Forecast for Barbiturates Market (Million US$), 2024 – 2030
Figure-25: Local Anesthesia – Bupivacaine Market (Million US$), 2018 – 2023
Figure-26: Local Anesthesia – Forecast for Bupivacaine Market (Million US$), 2024 – 2030
Figure-27: Local Anesthesia – Ropivacaine Market (Million US$), 2018 – 2023
Figure-28: Local Anesthesia – Forecast for Ropivacaine Market (Million US$), 2024 – 2030
Figure-29: Local Anesthesia – Lidocaine Market (Million US$), 2018 – 2023
Figure-30: Local Anesthesia – Forecast for Lidocaine Market (Million US$), 2024 – 2030
Figure-31: Local Anesthesia – Chloroprocaine Market (Million US$), 2018 – 2023
Figure-32: Local Anesthesia – Forecast for Chloroprocaine Market (Million US$), 2024 – 2030
Figure-33: Local Anesthesia – Prilocaine Market (Million US$), 2018 – 2023
Figure-34: Local Anesthesia – Forecast for Prilocaine Market (Million US$), 2024 – 2030
Figure-35: Local Anesthesia – Benzocaine Market (Million US$), 2018 – 2023
Figure-36: Local Anesthesia – Forecast for Benzocaine Market (Million US$), 2024 – 2030
Figure-37: Local Anesthesia – Other local anesthetics Market (Million US$), 2018 – 2023
Figure-38: Local Anesthesia – Forecast for Other local anesthetics Market (Million US$), 2024 – 2030
Figure-39: Baxter International Inc. – Market (Million US$), 2018 – 2023
Figure-40: Baxter International Inc. – Forecast for Market (Million US$), 2024 – 2030
Figure-41: Abbvie – Global Revenue (Billion US$), 2018 – 2023
Figure-42: Abbvie – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-43: Medtronic Plc – Global Revenue (Billion US$), 2018 – 2023
Figure-44: Medtronic Plc – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-45: Draegerwerk AG – Global Revenue (Billion US$), 2018 – 2023
Figure-46: Draegerwerk AG – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-47: Koninklijke Philips NV – Global Revenue (Billion US$), 2018 – 2023
Figure-48: Koninklijke Philips NV – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-49: Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2023
Figure-50: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2024 – 2030

List of Tables

Table-01: United States – Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-02: United States – Forecast for Anesthesia Drugs Market Share (Million US$), 2024 – 2030
Table-03: United States – General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2018 – 2023
Table-04: United States – Forecast for General Inhalation Anesthesia Drugs Market Market Share (Million US$), 2024 – 2030
Table-05: United States – General Intravenous Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-06: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Million US$), 2024 – 2030
Table-07: United States – Local Anesthesia Drugs Market Share (Million US$), 2018 – 2023
Table-08: United States – Forecast for Local Anesthesia Drugs Market Share (Million US$), 2024 – 2030